Patents by Inventor Henrik Von Wachenfeldt

Henrik Von Wachenfeldt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES
    Publication number: 20220298151
    Abstract: The present disclosure relates to compounds according to Formula (I), useful for treating diseases.
    Type: Application
    Filed: May 27, 2022
    Publication date: September 22, 2022
    Applicant: ACADIA PHARMACEUTICALS INC.
    Inventors: Ethan S. BURSTEIN, Roger OLSSON, Björn Gustav BORGSTRÖM, Karl Erik JANSSON, Niklas Patrik SKÖLD, Henrik VON WACHENFELDT, Larisa Yudina WAHLSTRÖM
  • Compounds, salts thereof and methods for treatment of diseases
    Patent number: 11440884
    Abstract: The present disclosure relates to compounds according to Formulae (I), (II) and (VIII), useful for treating diseases.
    Type: Grant
    Filed: August 20, 2018
    Date of Patent: September 13, 2022
    Assignee: ACADIA PHARMACEUTICALS INC.
    Inventors: Ethan S. Burstein, Roger Olsson, Karl Erik Jansson, Niklas Patrik Sköld, Larisa Yudina Wahlström, Björn Gustav Borgström, Henrik Von Wachenfeldt, Magnus Gustav Wilhelm Bergner
  • Compounds, salts thereof and methods for treatment of diseases
    Patent number: 11345693
    Abstract: The present disclosure relates to compounds according to Formula (I), useful for treating diseases.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: May 31, 2022
    Assignee: ACADIA PHARMACEUTICALS INC.
    Inventors: Ethan S. Burstein, Roger Olsson, Björn Gustav Borgström, Karl Erik Jansson, Niklas Patrik Sköld, Henrik Von Wachenfeldt, Larisa Yudina Wahlström
  • COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES
    Publication number: 20210122713
    Abstract: The present disclosure relates to compounds according to Formulae (I), (II) and (VIII), useful for treating diseases.
    Type: Application
    Filed: August 20, 2018
    Publication date: April 29, 2021
    Applicant: ACADIA PHARMACEUTICALS INC.
    Inventors: Ethan S. BURSTEIN, Roger OLSSON, Karl Erik JANSSON, Niklas Patrik SKÖLD, Larisa Yudina WAHLSTRÖM, Björn Gustav BORGSTRÖM, Henrik VON WACHENFELDT, Magnus Gustav Wilhelm BERGNER
  • COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES
    Publication number: 20200270239
    Abstract: The present disclosure relates to compounds according to Formula (I), useful for treating diseases.
    Type: Application
    Filed: February 21, 2020
    Publication date: August 27, 2020
    Applicant: ACADIA PHARMACEUTICALS INC.
    Inventors: Ethan S. BURSTEIN, Roger OLSSON, Björn Gustav BORGSTRÖM, Karl Erik JANSSON, Niklas Patrik SKÖLD, Henrik VON WACHENFELDT, Larisa Yudina WAHLSTRÖM
  • NOVEL GALACTOSIDE INHIBITORS OF GALECTINS
    Publication number: 20140200190
    Abstract: Compounds having an effect as i.a. galectin inhibitors, to the use of said compounds as a medicament, as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to receptors in a mammal, wherein the galectin is preferably a galectin-3.
    Type: Application
    Filed: March 17, 2014
    Publication date: July 17, 2014
    Applicant: Galecto Biotech AB
    Inventors: Hakon LEFFLER, Ulf J. NILSSON, Henrik VON WACHENFELDT
  • Galactoside inhibitors of galectins
    Patent number: 8703720
    Abstract: Compounds having an effect as i.a. galectin inhibitors, to the use of said compounds as a medicament, as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to receptors in a mammal, where in the galectin is preferably a galectin-3.
    Type: Grant
    Filed: April 26, 2010
    Date of Patent: April 22, 2014
    Assignee: Galecto Biotech AB
    Inventors: Hakon Leffler, Ulf J. Nilsson, Henrik Von Wachenfeldt
  • NOVEL GALACTOSIDE INHIBITORS OF GALECTINS
    Publication number: 20120165277
    Abstract: Compounds having an effect as i.a. galectin inhibitors, to the use of said compounds as a medicament, as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to receptors in a mammal, where in the galectin is preferably a galectin-3.
    Type: Application
    Filed: April 26, 2010
    Publication date: June 28, 2012
    Applicant: FORSKARPATENT I SYD AB
    Inventors: Hakon Leffler, Ulf J. Nilsson, Henrik Von Wachenfeldt